Onconetix, Inc.
ONCO
$3.53
$0.185.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.82% | -85.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.82% | -85.73% | |||
| Cost of Revenue | -35.48% | 7.31% | |||
| Gross Profit | 53.93% | -93.06% | |||
| SG&A Expenses | -9.00% | 287.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.48% | 262.43% | |||
| Operating Income | 18.84% | -825.23% | |||
| Income Before Tax | 72.24% | 71.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 72.24% | 70.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 72.24% | 70.97% | |||
| EBIT | 18.84% | -825.23% | |||
| EBITDA | 18.83% | -574.68% | |||
| EPS Basic | 89.41% | 86.59% | |||
| Normalized Basic EPS | 67.98% | -166.31% | |||
| EPS Diluted | 89.41% | 86.59% | |||
| Normalized Diluted EPS | 67.98% | -166.31% | |||
| Average Basic Shares Outstanding | 162.05% | 115.09% | |||
| Average Diluted Shares Outstanding | 162.05% | 115.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||